Luteolin improves the impaired nerve functions in diabetic neuropathy: Behavioral and biochemical evidences

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 10112-10120

  Li, Ming ^a   Li, Qiang ^a   Zhao, Qingsong ^a   Zhang, Jinchao ^a   Lin, Jiang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Diabetic neuropathy; Luteolin; Neuroprotection; Nrf2

Indexed keywords

LUTEOLIN; MALONALDEHYDE; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL; ANIMAL BEHAVIOR; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE RESPONSE; DRUG EFFECTS; HYPERALGESIA; MALE; METABOLISM; NERVE CONDUCTION; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSICAL STIMULATION; PHYSIOLOGY; RAT; SPINAL GANGLION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; BEHAVIOR, ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; HYPERALGESIA; LUTEOLIN; MALE; MALONDIALDEHYDE; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; PAIN THRESHOLD; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 85013115056     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-321.
2. Didangelos T, Doupis J, Veves A. Painful diabetic neuropathy: clinical aspects. Handb Clin Neurol 2014; 126: 53-61.
3. Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes 2015; 6: 432-444.
4. Iyer S, Tanenberg RJ. Pharmacologic management of diabetic peripheral neuropathic pain. Expert Opin Pharmacother 2013;14: 1765-1775.
5. Negi G, Kumar A, Joshi RP, Sharma SS. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem Biophys Res Commun 2011; 408: 1-5.
6. Hosseini A, Abdollahi M. Diabetic neuropathy and oxidative stress: therapeutic perspectives. Oxid Med Cell Longev 2013; 2013: 168039.
7. Galuppo M, Giacoppo S, Bramanti P, Mazzon E. Use of natural compounds in the management of diabetic peripheral neuropathy. Molecules 2014; 19: 2877-2895.
8. Tan SM, de Haan JB. Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much? Redox Rep 2014; 19: 107-117.
9. Negi G, Kumar A, Sharma SS. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. J Pineal Res 2011; 50: 124-131.
10. Song MY, Kim EK, Moon WS, Park JW, Kim HJ, So HS, Park R, Kwon KB, Park BH. Sulforaphane protects against cytokine-and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway. Toxicol Appl Pharmacol 2009; 235: 57-67.
11. Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, Zhang DD. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 2010; 59: 850-860.
12. He X, Kan H, Cai L, Ma Q. Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. J Mol Cell Cardiol 2009; 46: 47-58.
13. Zhang YC, Gan FF, Shelar SB, Ng KY, Chew EH. Antioxidant and Nrf2 inducing activities of luteolin, a flavonoid constituent in Ixeris sonchifolia Hance, provide neuroprotective effects against ischemia-induced cellular injury. Food Chem Toxicol 2013; 59: 272-280.
14. Wruck CJ, Claussen M, Fuhrmann G, Römer L, Schulz A, Pufe T, Waetzig V, Peipp M, Herdegen T, Götz ME. Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl 2007; 72: 57-67.
15. Huang CS, Lii CK, Lin AH, Yeh YW, Yao HT, Li CC, Wang TS, Chen HW. Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes. Arch Toxicol 2013; 87: 167-178.
16. Wang GG, Lu XH, Li W, Zhao X, Zhang C. Protective Effects of Luteolin on Diabetic Nephropathy in STZ-Induced Diabetic Rats. Evid Based Complement Alternat Med 2011; 2011: 323171.
17. Ren G, Kong J, Jia N, Shang X. Luteolin attenuates neuronal apoptosis in the hippocampi of diabetic encephalopathy rats. Neural Regen Res 2013; 8: 1071-1080.
18. Vogelaar CF, Vrinten DH, Hoekman MF, Brakkee JH, Burbach JP, Hamers FP. Sciatic nerve regeneration in mice and rats: recovery of sensory innervation is followed by a slowly retreating neuropathic pain-like syndrome. Brain Res 2004; 1027: 67-72.
19. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77-88.
20. Chen L, Chen W, Qian X, Fang Y, Zhu N. Liquiritigenin alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model. Sci Rep 2014; 4: 5676.
21. Liu Y, Wang L, Li X, Lv C, Feng D, Luo Z. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats. Biochem Biophys Res Commun 2010; 399: 49-54.
22. Padiya R, Chowdhury D, Borkar R, Srinivas R, Pal Bhadra M, Banerjee SK. Garlic attenuates cardiac oxidative stress via activation of PI3K/AKT/Nrf2-Keap1 pathway in fructose-fed diabetic rat. PLoS One 2014; 9: e94228.
23. Ma J, Liu J, Wang Q, Yu H, Chen Y, Xiang L. The beneficial effect of ginsenoside Rg1 on Schwann cells subjected to hydrogen peroxide induced oxidative injury. Int J Biol Sci 2013; 9: 624-636.
24. Hara K, Haranishi Y, Terada T, Takahashi Y, Nakamura M, Sata T. Effects of intrathecal and intracerebroventricular administration of luteolin in a rat neuropathic pain model. Pharmacol Biochem Behav 2014; 125: 78-84.
25. Xu J, Wang H, Ding K, Zhang L, Wang C, Li T, Wei W, Lu X. Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway. Free Radic Biol Med 2014; 71: 186-195.
26. Paterniti I, Cordaro M, Campolo M, Siracusa R, Cornelius C, Navarra M, Cuzzocrea S, Esposito E. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation. CNS Neurol Disord Drug Targets 2014; 13: 1530-1541.
27. Paterniti I, Impellizzeri D, Di Paola R, Navarra M, Cuzzocrea S, Esposito E. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury. J Neuroinflammation 2013; 10: 91.
28. Qian LB, Wang HP, Chen Y, Chen FX, Ma YY, Bruce IC, Xia Q. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress. Pharmacol Res 2010; 61: 281-287.